Eva María Verdugo Sivianes-rekin lankidetzan egindako argitalpenak (2)

2020

  1. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

    Molecular Cancer, Vol. 19, Núm. 1

2019

  1. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1